Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Hematology/Oncology Clinics of North America|December 29, 2023
Chimeric Antigen Receptor T Cells in the Treatment of Multiple MyelomaZainul S Hasanali, Beatrice Razzo, Sandra P Susanibar-Adaniya, et al.
Transplantation and Cellular Therapy|May 23, 2025
Long-Term Financial Toxicity After CAR T-Cell Therapy Among Patients in Remission and Their CaregiversLucy P Andersen, Ryan J Quinn, Heather Difilippo, et al.
Seminars in Oncology Nursing|August 30, 2025
Factors Related to Long-Term Caregiving Burden Among Chimeric Antigen Receptor (CAR) T-Cell Recipients and Their Informal CaregiversLucy P Andersen, Ryan J Quinn, Heather Difilippo, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|November 1, 2007
Promoting professionalism through an online professional development portfolio: successes, joys, and frustrationsAdina L Kalet, Joseph Sanger, Julie Chase, et al.
Genes & Development|January 19, 2010
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasionVasilena Gocheva, Hao-Wei Wang, Bedrick B Gadea, et al.
Genes & Development|January 17, 2016
Combined deletion of cathepsin protease family members reveals compensatory mechanisms in cancerLeila Akkari, Vasilena Gocheva, Marsha L Quick, et al.
Frontiers in Oncology|August 14, 2025
A roadmap to implementing outpatient administration of bispecific antibodies in multiple myelomaAlfred L Garfall, Rahul Banerjee, Laurent Frenzel, et al.
Frontiers in Immunology|February 14, 2014
Trials and Tribulations with VH ReplacementWenzhao Meng, Sahana Jayaraman, Bochao Zhang, et al.
The Lancet. Haematology|December 22, 2015
Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot studyScott F Huntington, Brendan M Weiss, Dan T Vogl, et al.
Pageof 7